<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12-b-25
Commission File Number 0-13615
NOTIFICATION OF LATE FILING OF FORM 10-KSB
For the Period Ended: September 30, 1996
Part I. Registrant Information
CELLCOM CORP.
(Full name of registrant)
520 South Fourth Street, Las Vegas, Nevada 89101
(Address of Principal executive office)
Part II. Rule 12b-25 (a) and (b)
If the subject report could not be filed without unreasonable effort or
expense, and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box).
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort and expense;
[X] (b) The subject annual report on Form 10-KSB will be filed on or before
the 15th calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
Part III. Narrative
State below in reasonable detail the reasons why Form 10-KSB could not
be filed within the prescribed time period:
As a consequence of changes requested by reviewing parties, the
registrant has been delayed in completing its Form 10-KSB and is filing such
Form a few days late.
Part IV. Other Information
(1) Name and telephone number of person to contact in regard to this
notification:
David A. Obal (702) 896-8898
Name (Telephone #)
<PAGE> 2
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 during the preceding 12 months or for
such shorter period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
CELLCOM CORP.
(Name of registrant as specified in charter)
has caused the notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: December 31, 1996 By: /s/ David A. Obal
-----------------
Title: Chief Financial Officer
Instruction. The form may be signed by an executive officer of
the registrant or by any other duly authorized representative. If the
statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be
filed with the form.
ATTENTION:
Intentional misstatements or omissions of fact constitute Federal
criminal violations (see 18 U.S.C. 1001).
